UKRI: Funding for early stage development of new healthcare interventions

14/12/2023

13/03/2024

Apply for funding to generate critical preliminary data to build confidence in the development strategy for a new medicine, repurposed medicine, medical device, diagnostic test, or other medical intervention development. The idea for a new product that can improve human health should have already been conceived and supported by other funding. This should be utilised to produce the critical preliminary data needed to support the onward development of the product. Award range: £50,000 - £300,000.

You can apply for academically led translational projects that aim to undertake a focused package of work that will bridge the gap between the inception of a new idea and substantive funding through schemes such as the MRC Developmental Pathway Funding Scheme to: - help prevent disease - help improve speed and accuracy of diagnosis of disease - develop new treatments for disease - help to improve outcome monitoring of patients receiving treatment - help to improve the management of diseases and conditions All human diseases and medical interventions are eligible for support, both in the context of UK healthcare and addressing global health issues.

To be eligible to apply for this funding opportunity you must: be a researcher employed by an eligible research organisation show that you will direct the project and be actively engaged in the work be looking to generate critical preliminary data to build confidence in the development strategy for a new medicine, repurposed medicine, medical device, diagnostic test, or other medical intervention development If you do not have a contract of employment for the duration of the proposed project, by submitting an application the research organisation is confirming, if it is successful: contracts will be extended beyond the end date of the project all necessary support for you and the project will be provided, including mentorship and career development for early career researchers.